Literature DB >> 15257542

Biomorphometric analysis of human prostatic carcinoma by using three-dimensional computer models.

Priya N Werahera1, Gary J Miller, Kathleen Torkko, E David Crawford, J Scott Stewart, Edward P Deantoni, Heidi L Miller, M Scott Lucia.   

Abstract

Advances in the detection of carcinoma of the prostate during the last 15 years have accounted for a sharp increase and then an abrupt decrease in the incidence of the disease. A more recent decline in its mortality rates has been variously interpreted as either the success of early detection and improved treatment or lead-time bias. The recently reported Prostate Cancer Prevention Trial had an overall detection rate that approached the 30%-40% prevalence rates reported in autopsy series in which men died of other causes. However, the prognostic information that can be obtained from prostate cancer found on biopsy is limited. Three-dimensional computer modeling is one technique that allows multiple studies on "immortal" prostates to test methods of biopsy sampling accuracy and to assist in the determination of the disease's severity. Computer modeling can assess detection rates and assesses tumor multifocality and heterogeneity. It can provide a more accurate representation of tumor volume, aiding in therapeutic decision making, and can assess sampling errors of various biopsy methods. It has been shown to be superior to wire-frame technique by immortalizing the original shape and dimensions of the surgically excised prostate gland. Moreover, our 3-dimensional computer modeling system improves upon other systems: It is more than a simple extension of the planimetric technique, and it is able to demarcate clearly the boundaries of Gleason grades just 1 grade apart.

Entities:  

Mesh:

Year:  2004        PMID: 15257542     DOI: 10.1016/j.humpath.2004.02.015

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Anterior tumors of the prostate: diagnosis and significance.

Authors:  Priya N Werahera; E David Crawford; Francisco G La Rosa; Kathleen C Torkko; Beth Schulte; Holly T Sullivan; Adrie van Bokhoven; M Scott Lucia; Fernando J Kim
Journal:  Can J Urol       Date:  2013-10       Impact factor: 1.344

2.  Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens.

Authors:  E David Crawford; Kyle O Rove; Al B Barqawi; Paul D Maroni; Priya N Werahera; Craig A Baer; Hari K Koul; Cory A Rove; M Scott Lucia; Francisco G La Rosa
Journal:  Prostate       Date:  2012-11-20       Impact factor: 4.104

3.  Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species.

Authors:  Jenean O'Brien; Traci Lyons; Jenifer Monks; M Scott Lucia; R Storey Wilson; Lisa Hines; Yan-gao Man; Virginia Borges; Pepper Schedin
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

4.  Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.

Authors:  Kenneth A Iczkowski; Kathleen C Torkko; Gregory R Kotnis; R Storey Wilson; Wei Huang; Thomas M Wheeler; Andrea M Abeyta; Francisco G La Rosa; Shelly Cook; Priya N Werahera; M Scott Lucia
Journal:  Am J Clin Pathol       Date:  2011-07       Impact factor: 2.493

5.  Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens.

Authors:  Okyaz Eminaga; Reemt Hinkelammert; Axel Semjonow; Joerg Neumann; Mahmoud Abbas; Thomas Koepke; Olaf Bettendorf; Elke Eltze; Martin Dugas
Journal:  BMC Med Inform Decis Mak       Date:  2010-11-15       Impact factor: 2.796

6.  Proliferative tumor doubling times of prostatic carcinoma.

Authors:  Priya N Werahera; L Michael Glode; Francisco G La Rosa; M Scott Lucia; E David Crawford; Kenneth Easterday; Holly T Sullivan; Rameshwar S Sidhu; Elizabeth Genova; Tammy Hedlund
Journal:  Prostate Cancer       Date:  2011-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.